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OBJECTIVES: Approximately one-third of candidates for epilepsy surgery have no visible abnormalities on
conventional magnetic resonance imaging. This is extremely discouraging, as these patients have a less
favorable prognosis. We aimed to evaluate the utility of quantitative magnetic resonance imaging in patients
with drug-resistant neocortical focal epilepsy and negative imaging.
METHODS: A prospective study including 46 patients evaluated through individualized postprocessing of five
quantitative measures: cortical thickness, white and gray matter junction signal, relaxation rate, magnetization
transfer ratio, and mean diffusivity. Scalp video-electroencephalography was used to suggest the epileptogenic
zone. A volumetric fluid-attenuated inversion recovery sequence was performed to aid visual inspection.
A critical assessment of follow-up was also conducted throughout the study.
RESULTS: In the subgroup classified as having an epileptogenic zone, individualized postprocessing detected
abnormalities within the region of electroclinical origin in 9.7% to 31.0% of patients. Abnormalities outside the
epileptogenic zone were more frequent, up to 51.7%. In five patients initially included with negative imaging,
an epileptogenic structural abnormality was identified when a new visual magnetic resonance imaging
inspection was guided by information gleaned from postprocessing. In three patients, epileptogenic lesions
were detected after visual evaluation with volumetric fluid-attenuated sequence guided by video electro-
encephalography.
CONCLUSION: Although quantitative magnetic resonance imaging analyses may suggest hidden structural
lesions, caution is warranted because of the apparent low specificity of these findings for the epilepto-
genic zone. Conversely, these methods can be used to prevent visible lesions from being ignored, even in
referral centers. In parallel, we need to highlight the positive contribution of the volumetric fluid-attenuated
sequence.
KEYWORDS: Drug-Resistant Epilepsy; Magnetic Resonance Imaging; Multimodal Imaging; Computer-Assisted
Image Processing.
’ INTRODUCTION
Epilepsy is defined as a brain disease defined by any of the
following conditions: 1) at least two unprovoked (or reflex)
seizures occurring424h apart; 2) one unprovoked (or reflex)
seizure and a probability of further seizures similar to the
general recurrence risk (at least 60%) after two unprovoked
seizures, occurring over the next 10 years; and 3) diagnosis of
an epilepsy syndrome (1). Epilepsy affects more than 50DOI: 10.6061/clinics/2019/e908
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million people worldwide and is considered a public health
problem (2).
Symptomatic focal epilepsies account for approximately
60% of all cases, and approximately one-third of these patients
present with drug-resistant epilepsy despite adequate trials of
two tolerated, appropriately chosen and used antiepileptic
drug regimens. In selected cases, epilepsy surgery may be
indicated for seizure control (3).
Magnetic resonance imaging (MRI) has emerged as an
indispensable tool for the preoperative localization of epi-
leptogenic lesions in people with drug-resistant epilepsy (3).
Important issues to consider during MRI evaluation of the
epileptic patient, which may increase sensitivity for detecting
structural abnormalities, include the use of specific protocols,
expertise of the neuroradiologist, and use of the strongest
magnetic field available (4,5).
Approximately one-third of candidates for epilepsy sur-
gery have no visible abnormalities on conventional MRI (3).
In other words, even if an epileptogenic lesion exists, it may
be invisible on conventional MRI sequences, especially when
subtle focal cortical dysplasia (FCD) is present. This is extre-
mely discouraging, as patients without visible lesions on
MRI are also less likely to be referred for surgery and,
following surgery, have a less favorable prognosis than those
with visible lesions on MRI (6).
Quantitative MRI techniques involving individualized
postprocessing have been applied to this group of patients
and may increase sensitivity to detect focal abnormalities (7).
These methods are being used to improve the detection of
epileptogenic substrates, especially when conventional MRI
is inconclusive. Despite much published research on MR
neuroimaging, advanced MRI techniques, and quantitative
MRI analyses in patients with drug-resistant neocortical focal
epilepsy (DRNFE) and nonlesional epilepsy (NLE), the
literature is scarce regarding studies that evaluate several
quantitative methods and advanced sequences in the same
cohort of patients, and the few available studies have largely
been retrospective.
This study sought to evaluate, in a referral center for epi-
lepsy surgery, the utility of several quantitative MRI methods
with individualized postprocessing in a cohort of patients
with DRNFE, who were potential surgical candidates and
had been deemed nonlesional by 3-Tesla (3T) conventional
MRI.
’ METHODS
This was a prospective study of 46 patients (24 women)
with suspected neocortical focal epileptic seizures who were
potential candidates for surgery. All patients had NLE on
conventional MRI. Our routine MRI protocol for epilepsy
includes an axial turbo spin-echo T2-weighted sequence; a
coronal turbo spin-echo T2-weighted sequence perpendicu-
lar to the long axis of the hippocampus; a coronal fluid-
attenuated inversion recovery (FLAIR) image perpendicular
to the long axis of the hippocampus; an axial T2*-weighted
gradient-echo sequence or susceptibility-weighted imaging
(SWI); and a T1 magnetization-prepared rapid acquisition
gradient echo (MP-RAGE). High-resolution isotropic 3D-
FLAIR was also performed to aid visual inspections. This
sequence was not initially part of the protocol and was
performed in 16 patients (16/46 or 34.8%).
All procedures were in accordance with the ethical
standards of the institutional and/or national research
committee and with the 1964 Helsinki Declaration and its
later amendments or comparable ethical standards. Informed
consent was obtained from all individual participants.
The median age was 34.6 years (range, 20-51; SD,
8.0 years), the median age at the onset of seizures was 10.6
years (range, 0-29; SD, 7.3 years), and the median epilepsy
duration was 23 years (range, 8-39 years). All MRI examina-
tions were analyzed in the routine inspections of the imaging
center and multidisciplinary meetings by physicians with
expertise in epilepsy imaging.
Potential epileptogenic zones (EZs) were identified through
a review of surface video-electroencephalography (VEEG)
findings (Nihon-Koden). Patients were then classified as
having a suspected location for the focus (SLF) or no sus-
pected location for the focus (NSLF). Briefly, patients who had
symptoms and electrophysiological findings indicative of a
specific region/lobe and side of the brain were classified as
SLF, as were patients with relatively specific regionalization
(e.g., to the anterior frontal region, mesial frontal region, or
temporooccipital region) despite no lateralization. All other
patients were considered NSLF. Overall, 31 patients (67.4%)
were classified as SLF, and 15 (32.6%) were classified as NSLF.
All patients underwent a new 3T-MRI scan between March
2010 and June 2016 (Achieva Duo-scanner, Philips Medical
Systems, Best, Netherlands). This so-called advanced proto-
col included four sequences.
The first sequence was a sagittal 3D T1-weighted magneti-
zation-prepared rapid acquisition gradient echo (MP-RAGE),
TR/TI/TE 2500/900/2.9 ms, flip angle 8o, matrix 240 240,
field of view (FOV) 240 240, slice thickness 1.0 mm and no
gap, which was used for the analysis of cortical thickness
(CThk) and white and gray matter junction signal (WGJS) by
specific software.
The second sequence was an axial T2 relaxometry volu-
metric acquisition, TR/TE 3000/(20, 40, 60, 80, 100) ms, flip
angle 90o, matrix 240 180, FOV 240 180, slice thickness
3.0 mm and no gap. We calculated the T2 value for each
voxel by using the linear equation: ln (S)=-TE/T2+ln (S0).
Here, S and S0 represent the signal intensities for each echo
time and without relaxation effect, respectively.
The third acquisition was an axial 3D proton density-
weighted magnetization transfer imaging (MTI) sequence,
TR/TE 7.3/3.3 ms, flip angle 8o, matrix 240 180, FOV
240 178, slice thickness 3.0 mm and no gap. In this moda-
lity, two sets of dynamic images were acquired, without and
with a saturation pulse (MToff and MTon). The magnetiza-
tion transfer ratio (MTR) was calculated by the equation
MTR=[(MToff-MTon)/MToff]*100.
Finally, diffusion tensor imaging (DTI) axial acquisition was
performed along 36 optimized noncollinear directions, TR/TE
8900/65 ms, matrix 256 256, FOV 128 128, slice thickness
2.0 mm and no gap. A single b-value of 1000 s/mm was
applied, b-value measures the degree of diffusion weighting
applied. Following the findings of Thivard et al. and Chen
et al. (8,9), we chose mean diffusivity (MD) (the arithmetic
mean of the eigenvalues of the diffusion matrix after its
diagonalization) obtained directly from the scanner as the
parameter of the generated maps, as it correlates best with EZ.
The control groups were extracted from the database of the
imaging center of the institution where the research took place
and comprised healthy volunteers with no history of neuro-
logical disorders and normal conventional MRI (Table 1).
Although there was variation in N between the control groups,
the variances and distributions between them were similar.
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Statistical analysis and multimodal postprocessing
For statistical analyses to be conducted among different
subjects, MR images need to be spatially combined to fit a
standard space created by averaging a large number of scans,
known as ‘‘spatial normalization’’ (10,11). Other parameters
used to achieve optimal results include smoothing and
p-values. Smoothing consists of averaging the effect of adja-
cent regions for analysis, rather than being peer-to-peer. As
statistical analysis is usually based on a univariate approach
and comprises multiple tests, the problem of multiple
comparisons must be addressed to reduce false positive
results. To achieve this, in addition to smoothing, more res-
trictive p-values can be used to define statistical significance.
To facilitate visualization and localization of abnormalities,
neuroimaging software offers schematic visual identification
functions using standard models and standardized brains,
among other possibilities.
For analysis of CThk obtained from the 3D-T1 MP-RAGE
sequence, surface-based morphometry (SBM) findings were
assessed using the FreeSurfer software (Athinoula A.
Martinos Center for Biomedical Imaging at Massachusetts
General Hospital, Boston, MA, USA). The calculation of
CThk involves a processing flow in which the surface of the
pia mater and the interface between the white matter and the
gray matter are identified in a technique known as SBM. The
distance between these two lines is the CThk value (12). For
visual identification of the significantly different regions
through the QDEC tool of the FreeSurfer package, we used a
recent article as a reference for our choice of smoothing,
which was set at 10 mm (13).
To define the significance threshold, we used a false
discovery rate (FDR)-adjusted p-value p0.05, standardized
by the software, to be more restrictive than choosing a fixed
standard score (z-score) and consequently achieve a more
effective control of false positives.
The statistical test was the hypothesis test implemented
in the QDEC tool for comparison between one subject and
a group. Reported p-values were corrected for multiple com-
parisons (FDR=0.05 was selected), and permutation testing
was performed, also in the QDEC tool.
Before starting the evaluation of the patient scans, 30
individuals from the overall control cohort were individually
compared to the rest of the control group, and abnormalities
were revealed in three individuals. Because of the lack of
conformity in the literature regarding the control of false
positives, we found it reasonable to expand the rate of 10% of
false positives as the target to guide the choice of parameters
in the statistical evaluations of the other measures. Conse-
quently, in all evaluations, we used the same rate. Another
point that supports our decision is that most studies have
adopted a false positive rate higher than ours.
All other evaluations were carried out by plotting para-
metric maps with specific statistical inferences for a specific
voxel, the voxel-based analysis (VBA) technique. We used
Statistic Parametric Mapping (SPM12) software for these
analyses.
WGJS maps were extracted after segmentation of the T1-
weighted sequence into gray matter (GM), white matter
(WM), and cerebrospinal fluid. Binarized maps were used to
create a white–gray junction binary image following a pre-
viously described procedure (14). The main steps for WGJ
evaluation were as follows: 1) individual WM and GM
segmentation using SPM tools; 2) definition of the binary
WM and GM masks, considering voxels classified with high
probability (40.9) in each tissue class; 3) definition of indivi-
dual binary WGJ masks considering voxels with intensities
in the interval between Mean_GM-SD_GM and Mean_WM
+SD_WM; 4) convolution of individual binary WGJ masks
and a unitary 3D kernel (5 5 5 voxels); and 5) Z-score
maps were obtained for comparisons of each convolved
patient image and the mean convolved image of the healthy
control group. It bears stressing that a new mean convolved
WGJ map from the group of healthy controls was created in
this study.
The other maps were extracted from equations of their
respective sequences. T2 and MTR maps were obtained
from functions developed in-house using MINC tools. The
T2 relaxometry, MTR, and MD maps were registered to
an anatomical atlas space to normalize and identify those
anatomical labels with significant changes. We used a B-
spline interpolation as implemented in the SPM toolbox for
this normalization procedure. Maps with low spatial resolu-
tion are more affected by the interpolation step in this
normalization procedure.
In addition to smoothing and p-values, the SPM program
allows limiting recognition of changes to a contiguous
grouping of altered voxels (clusters); thus, small and very
isolated regions (probably related to noise) are not flagged as
abnormal. The p-values for all these maps were chosen from
an uncorrected p0.001 or a familywise error (FWE) p0.05,
both standardized by the software. As previously stated,
p-values and clusters of voxels were chosen after evaluations
for each measure with 20 individuals from the healthy
control group conducted to achieve the same rate of false
positives found in the CThk evaluation. Briefly, we then
performed tests with SPM12 to find p-values, first using an
uncorrected p-value p0.001 (less restrictive) and then an
FWE-corrected p-value p0.05 (more restrictive), associated
with the lowest threshold of voxel clusters that allowed
reaching the same rate of false positives (two last columns of
Table 1). We eliminated findings that were located outside
the cerebral parenchyma and distant from the cortex,
Table 1 - Characteristics of control groups and the parameters chosen after tests in each quantitative measure.
Quantitative
measure
n Median age
(years)
Range
(years)
SD
(years)
Smoothing
(mm)
p-value Cluster of
voxel
CThk 92 (27 men) 30.2 19-51 9.8 10 p0.05 (FDR) -
WGJS 92 (27 men) 30.2 19-51 9.8 8 FWHM p0.001
(uncorrected)
30
T2 53 (27 men) 30.9 18-51 9.1 6 FWHM p0.05 (FWE) 55
MTR 48 (30 men) 32.9 18-51 9.9 6 FWHM p0.05 (FWE) 30
MD 45 (28 men) 31.2 18-50 10.0 6 FWHM p0.05 (FWE) 40
CThk, cortical thickness; WGJS, white–gray matter junction signal; T2, T2 relaxometry maps; MTR, magnetization transfer rate; MD, mean diffusivity;
FWHM, full width at half maximum; FDR, false discovery rate; FWE; familywise error.
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i.e., anything found in the ventricles, cisterns, sulcus,
brainstem, and cerebellum, as well as in the skull bone itself
and outside the skull.
Patients were evaluated for the presence of abnormalities
in the individualized postprocessing of each quantitative
measure. In patients classified as SLF, we considered that
there was agreement between methods (electroclinical versus
quantitative MRI) if the region or lobe pinpointed by MRI
findings corresponded to the electroclinical source of the
seizures.
Visual evaluation of conventional MRI with
specific localization guided by individualized
postprocessing
The location of each abnormality in individualized post-
processing was noted to enable subsequent targeted visual
inspection of conventional scans and identification of some
previously undetected, subtle structural abnormalities. In
cases where previously unidentified epileptogenic structural
lesions were identified, we investigated what postprocessing
measure allowed this detection. All sequences that are part of
the routine MRI protocol for epilepsy were used at this stage.
Critical assessment of patients’ follow-up
After analyzing the quantitative data, we also performed a
retrospective evaluation of all patients. In cases where
previously unidentified epileptogenic structural lesions were
detected during the time of data collection, we investigated
whether the additional MRI sequences allowed such detec-
tion and whether the new visual inspection was guided by
another method, notably VEEG.
’ RESULTS
Statistical analysis and multimodal postprocessing
A compilation of the results of quantitative analysis through
individualized postprocessing in the 46 patients is given in
Table 2. A close correlation (even lobe) between the abnormal
findings in at least two of these quantitative measures, which
also corresponded to the electroclinical origin of the seizures,
was identified in five patients in this group (5/31, 16.1%)
(Figure 1).
Visual evaluation of conventional MRI with
specific localization guided by individualized
postprocessing
In five patients (10.9%) included in the study as NLE based
on conventional MRI, an epileptogenic structural abnorm-
ality was identified on the conventional scans only after
targeted visual evaluation guided by the quantitative MRI
measures. All these findings were confirmed by the physi-
cians in charge of imaging and epilepsy surgery. These
patients are still in the process of being assessed for surgical
referral. Three of those five patients were classified as SLF,
but in one, there was disagreement between the location
suggested by the electroclinical evaluation and the region of
the suspected finding on MRI. The other two were con-
sidered NSLF by VEEG. SBM evaluation of the CThk was
used in four patients (Figure 2), while VBA of WGJS was
used in one patient.
In one patient, there was concordance between the
findings of the SBM evaluation, VBA of T2 maps, and the
structural abnormality found on visual inspection of con-
ventional MR images (Figure 3).
Table 2 - Quantitative MRI findings in 46 patients with drug-resistant focal epilepsy
Positive findings No. of patients/all
patients with available data (%)
CThk WGJS MTR T2 MD Overall
In any lobe or region of the cerebral
hemispheres
15/46 (32.6%) 17/46 (36.9%) 15/38 (39.5%) 20/41 (48.8%) 22/39 (56.4%) 39/46 (84.8%)
SLF corresponding to the presumed
electroclinical source of the
seizures
3/31 (9.7%) 3/31 (9.7%) 4/26 (15.4%) 7/28 (25.0%) 9/29 (31.0%) 16/31 (51.6%)
SLF not corresponding to the
presumed electroclinical source
of the seizures
8/31 (25.8%) 9/31 (29.0%) 9/26 (34.6%) 9/28 (32.1%) 15/29 (51.7%) 26/31 (83.9%)
Postprocessing failures 0 0 8/46 (17.4%) 5/46 (10.9%) 7/46 (15.2%) 16/46 (34.8%)
CThk, cortical thickness; WGJS, white–gray matter junction signal; T2, T2 relaxometry maps; MTR, magnetization transfer rate; MD, mean diffusivity; SLF,
suspected location of epileptogenic focus.
Figure 1 - Example of a patient with a presumed epileptogenic zone in the left frontotemporal region (patient 7) that was concordant
with three quantitative measures. The results of postprocessing of T2 relaxometry maps by Statistic Parametric Mapping (SPM12)
software (a: coronal plane) and mean diffusion maps (b: sagittal plane), as well as cortical thickness by FreeSurfer (c: quadrature
decoder [QDEC]), showing abnormalities notably in the left frontal lobe.
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Critical assessment of patients’ follow-up
In this retrospective evaluation, three patients initially
included in the study as NLE based on conventional MRI
showed some structural alterations after targeted visual
evaluation guided by VEEG. All underwent surgery and
were diagnosed with FCD. Among these patients, 3D-FLAIR
was the only sequence that allowed the identification of
cortical involvement (Figure 4). In parallel, in two of the five
patients in whom postprocessing guided the detection of
structural alterations, the 3D-FLAIR sequence allowed for a
clearer characterization of lesions.
’ DISCUSSION
We used two techniques for individualized image proces-
sing, SBM in FreeSurfer software to measure CThk and VBA
in SPM12 software for the other measures (WGJS, T2, MTR,
and MD), with the aim of identifying cerebral abnormalities
that could not be detected by visual inspection of conven-
tional MR images in a group of patients with DRNFE, who
were potential surgical candidates and had been deemed
‘‘negative’’ or ‘‘nonlesional’’ MRI. Specifically, our objective
was to then evaluate the utility of these quantitative measures
in this same group of consecutively enrolled patients, as the
literature is very scarce in relation to the use of these MRI
techniques within single cohorts, and most studies have been
retrospective (7).
Postprocessing techniques require that images first be
normalized in a standard space so that equivalent regions
can be compared (10,11). Although there is no common
statistical threshold for all studies that apply automatic and
individualized postprocessing methods, a routine practice in
Figure 2 - Images from patient 24 who was initially classified as magnetic resonance imaging (MRI) negative. After visual evaluation
guided by postprocessing, a potentially epileptogenic structural lesion was identified in the same region considered the epileptogenic
zone by electroclinical data. A) Results of the postprocessing of cortical thickness in the FreeSurfer software environment, showing
cortical thickening in the left inferior temporooccipital transition. Nonvolumetric coronal fluid attenuation inversion recovery (FLAIR)
(B) and T2 short tau inversion recovery (STIR) with inverted window (C) acquisitions showing discrete focal cortical thickening and
white–gray transition blurring (white circles) in the same region identified by the quantitative analysis.
Figure 3 - Example of a patient who switched to positive magnetic resonance imaging (MRI) status only after targeted visual evaluation
guided by postprocessing (patient 19). A possible epileptogenic zone had not been regionalized in this patient with video
electroencephalography. However, he exhibited abnormalities in the same region by two quantitative measures. a) Postprocessing of
cortical thickness (quadrature decoder [QDEC]) showed temporo-insular thickening in the right hemisphere (blue image). b) Evaluation
of T2 relaxometry maps with Statistic Parametric Mapping (SPM12) software also revealed a signal abnormality in the same location
(yellow and red foci). c) Coronal T2 short tau inversion recovery (STIR) (inverted window) showing cortical thickening in the same
region (black arrows).
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this type of work—in which analyses are aimed at individual
diagnosis, and false positive results need to be minimized—
is a comparison of healthy individuals from the control
group with the rest of the control group. In addition, most
studies still use an arbitrary strategy to control the false
positive rate; the parameters to be used (smoothing/clusters
and p-values / z-scores) are initially chosen, and then the
false positives are detected (7). Conversely, we decided to use
a strategy that involved controlling and standardizing the
false positive rate after an initial analysis, as previously
described, since we considered a 10% false positive rate
acceptable. As an example, some studies have worked with a
detection rate of abnormalities in up to 68% of healthy
individuals, demonstrating the difficulty in controlling this
variable in an individual versus group evaluation (7,15).
Individual quantitative measurements detected abnormal-
ities in any region of the brain in up to 56.4% of patients for
each measurement. It is reasonable to assume that these
findings are probably due to the epilepsy per se. In the
subgroup of patients classified as SLF, quantitative measure-
ments detected abnormalities in the presumed EZ at
percentages ranging from 9.7% (3/31) to 31.0% (9/29) of
patients with available data for each measurement. The higher
increase in diagnostic yield was obtained with MD (31.0%, 9/
29). However, signal abnormalities observed outside the
presumed EZ were always more prevalent. Therefore, caution
is recommended in the further use of these findings; if
necessary, other methods, including invasive EEG recording
with stereo-EEG, should be pursued for confirmation.
Previous studies of individualized postprocessing have
reported good agreement between the techniques of quanti-
tative evaluation and conventional visual analysis, as well as
promising results with the use of these techniques in MRI-
negative patients, indicating the potential capacity to detect
epileptogenic lesions not visible on conventional imaging (7).
In parallel, most studies using some of these techniques
reported the same limitation found in our study regarding a
more frequent rate of positive findings outside the presumed
EZ; thus, this question persists as the main limitation to be
approached in future studies (7,15,16). Salmenpera et al., for
example, assessed four quantitative measures (T2, MTR,
and two gray matter distributions) in the same group of
patients with drug-resistant focal epilepsy and negative
MRI through individualized postprocessing with the SPM
program (16). They reported concordance between VEEG
findings and MRI signal abnormalities of up to 15.8%.
In addition, signal changes outside the region of the electro-
clinical origin of seizures were observed in up to 42% of
patients.
First, the analysis of these quantitative data obtained
from MR sequences in our study was largely based on a
comparison with the presumed EZ as determined by surface
VEEG findings. This technique is associated with some
limitations, but it provided the most appropriate localized
data for these patients available at the time of the study. In
addition to the difficulty of determining regionalization and
lateralization in a significant number of patients, there is still
the problem of the possibility of misleading localization of
the EZ (17). This means that, in some patients, the signal
abnormalities identified in postprocessing that are outside
the regions presumably considered the EZ may reflect the
actual epileptogenic focus.
It is also important to point out that the network involved
in the seizure can be more widespread, probably explaining
the widespread abnormalities observed in quantitative
measurements (18,19). Despite the well-described relation-
ship between FCD (the main cause of seizures in this group
of patients) and the alterations found in the quantitative
Figure 4 - Example of a patient with no lesion (patient 39) in the first magnetic resonance imaging (MRI), exemplified by axial T2-
weighted MRI (a), axial nonvolumetric fluid attenuation inversion recovery (FLAIR) (b) and axial reconstruction of three-dimensional
(3D) T1-weighted MRI (c). After targeted visual evaluation guided by video-electroencephalography and 3D-FLAIR sequence, discrete
focal cortical thickening and a blurring of the transition between the white and gray matter highlighted inside the white circles in the
axial reconstructions were identified (d,e). The anatomohistopathological result was focal cortical dysplasia (f,c,d). Even retrospectively,
it is difficult to characterize any structural change in the routine protocol sequences for epilepsy (white arrows) (a–c). The axial double
inversion recovery (DIR) sequence (f) is also negative (white circle).
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measures in epileptogenic regions, we cannot automatically
relate abnormalities identified in postprocessing to the
presence of an EZ.
It is worth noting that it is unclear whether a correlation
between abnormalities evidenced by quantitative postproces-
sing methods, the electroclinical origin of seizures, and the
resected region in patients who undergo epilepsy surgery
without any visible epileptogenic structural alterations on
conventional MRI has any influence on postoperative out-
comes (7). However, there is ample literature on the significant
benefits of the identification of potentially epileptogenic
structural lesions on conventional MRI in the preoperative
evaluation of candidates for surgery (6). Thus, we consider it
very relevant that, even in a hospital recognized as a referral
center for epilepsy surgery, we were able to reduce the
number of patients classified as NLE when we used the
location of abnormalities identified on postprocessing to guide
visual inspection of conventional MRI. It is still important to
emphasize that the patients analyzed in this study are part of
a very challenging group, in which there are difficulties in the
definition of the EZ even after multimodal (electrophysiolo-
gical, functional and imaging) evaluation.
Indeed, the detection of potentially epileptogenic struc-
tural lesions improved in 5 out of 46 patients (10.9%). Two of
these had been classified as NSLF by VEEG and could now
be further investigated for EZ localization with a more pre-
cise, targeted approach. In one patient, quantitative findings
were discordant with the purported electroclinical origin of
the seizures. This disagreement did not cause postprocessing
findings to be discarded, but it does suggest the need for
greater caution in further investigations. In practice, this
means that if these patients are to undergo surgery, they will
benefit from the significant positive impact of having a
lesional MRI (6).
Moreover, by adding the patients in the retrospective
analysis, we included a total of eight patients (17.4%) who
presented with some potentially epileptogenic abnormalities
and were initially not characterized after visual evaluation
guided by postprocessing and/or VEEG. In five of these
patients, the 3D-FLAIR sequence provided significant ben-
efits to the analysis, and in three patients, this sequence was
the only one that allowed us to suspect FCD. These results
are in line with those of Saini et al. (20), who concluded that
this sequence should be included, especially when the MRI is
considered negative and the patient is a candidate for
surgery. This improvement in the diagnosis rate can be
explained by the higher spatial resolution and the possibility
of multiplanar reconstructions.
Finally, FLAIR-VBM has been recently used for the
detection of cortical lesions in a group of patients with
epilepsy and has presented superior results than T1-VBM
(7,15). The main advantage of FLAIR-VBM over T1-VBM
consists of the use of the T2 contrast typically found in FCD.
Our study did not assess 3D-FLAIR because this technique
was incorporated into the routine MRI protocol for epilepsy.
Other forms of evaluation of FLAIR and T1-VBM junction
maps are also worth mentioning; for example, Wang et al.
(21,22) used a morphometric analysis program (MAP) and
found excellent correlations between FCD MAP+ regions.
However, these studies were retrospective. Future pro-
spective studies will be essential to test these and other
quantitative techniques.
’ CONCLUSION
Quantitative MRI evaluation of selected parameters
through individualized postprocessing seems capable of
identifying hidden structural alterations in patients with
DRNFE. However, caution should be exercised when
analyzing abnormalities identified through these techniques
alone due to their apparently low specificity for EZ
determination. These findings identified on postprocessing
in this sample of patients generated several hypotheses;
further research to test these hypotheses is warranted. In
addition, as new techniques and sequences with higher
spatial resolution become available, new studies should be
carried out with the purpose of evaluating their utility and
efficiency for the identification of epileptogenic structural
lesions. Consequently, other methods, including invasive
EEG recordings with stereo-EEG, may be performed to
confirm that these findings indeed represent EZs.
Above all, our study showed the possibility of enhanced
performance and detection of potentially epileptogenic
lesions that had gone unnoticed on visual analysis of
conventional MRI through targeted re-evaluation of such
images guided by postprocessing. We also highlight the
significant positive contribution of the 3D-FLAIR sequence in
the detection of initially overlooked MRI lesions and reiterate
that repeated visual analysis is an easy and readily available
tool that should always be used while further research on
these quantitative techniques is being conducted.
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